Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Genentech Tau Probe 1
Alzheimer Disease
Washington University School of Medicine
P2
BB
(69)
Glutathione
Parkinson Disease
Gateway Institute for Brain Research
P2
BB
(69)
Hydroxyurea
Acute Myeloid Leukemia
Uma Borate
P2
BB
(69)
Idarubicin
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P2
BB
(69)
Idarubicin
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P2
BB
(69)
Ighv3-66*01 (81.4%) -(Ighd) -Ighj1*01 (100%), Cdr-Imgt [8.7.6] (26-33.51-57.96-101)) (1-112) -Homo Sapiens Ighg1*03V, G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14, 8-G1V29 Ch2 A84.4 (Ch1 R120>K (209) (113-210), Hinge 1-15 (211-225), Ch2 N84.4>A (292) (226-335), Ch3 E12 (351), M14 (353) (336-440), Chs (441-442)) (113-442)], (215-216')-Disulfide With L-Kappa Light Chain Humanized (1'-216') [V-Kappa (Homo Sapiens Igkv1-5*01 (85.4%) -Igkj1*01 (90.0%) Q120>G (102'), Cdr-Imgt [7.3.10] (27'-33'.51'-53'.90'-99')) (1'-109') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (C-Kappa A45.1 (155'), V101 (193')) (110'-216')]; Dimer (221-221'':224-224'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-Dg44, Non-Glycosylated
Migraine Disorder
H. Lundbeck A/S
P2
BB
(69)
Indocyanine Green
Hepatocellular Carcinoma
University of Florida
P2
BB
(69)
Loratadine
Breast Cancer
Noha Mansour
P2
BB
(69)
Lsd
Major Depressive Disorder
Johns Hopkins University
P2
BB
(69)
LY-2940094
Major Depressive Disorder
Mclean Hospital
P2
BB
(69)
Melphalan
HIV Infectious Disease
AIDS Malignancy Consortium
P2
BB
(69)
Melphalan
Myelofibrosis
Center for International Blood and Marrow Transplant Research
P2
BB
(69)
Mesna
Acute Leukemia
Center for International Blood and Marrow Transplant Research
P2
BB
(69)
Mesna
Acute Myeloid Leukemia
Center for International Blood and Marrow Transplant Research
P2
BB
(69)
Mesna
Disease Related To Hematopoietic Stem Cell Transplant
National Cancer Institute (NCI)
P2
BB
(69)
Mesna
Hodgkins Lymphoma
St. Jude Children's Research Hospital
P2
BB
(69)
Nelistotug (Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cd96 (T Cell Activation Increased Late Expression, Tactile, T-Cell Surface Protein Tactile)], Homo Sapiens Monoclonal Antibody)
Neoplasm
GlaxoSmithKline
P2
BB
(69)
Nivolumab
Cholangiocarcinoma
Instituto do Cancer do Estado de São Paulo
P2
BB
(69)
Nivolumab
Follicular Lymphoma
Olivia Newton-John Cancer Research Institute
P2
BB
(69)
Nivolumab
Gastric Cancer
I-Mab Biopharma US Limited
P2
BB
(69)
Nivolumab
Gastroesophageal Junction Adenocarcinoma
I-Mab Biopharma US Limited
P2
BB
(69)
Nivolumab
Head And Neck Squamous Cell Carcinoma
Fred Hutchinson Cancer Center
P2
BB
(69)
Nivolumab
Metastatic Prostate Carcinoma
Parabilis Medicines, Inc.
P2
BB
(69)
Nivolumab
Neuroblastoma
Instituto do Cancer do Estado de São Paulo
P2
BB
(69)
Nivolumab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(69)
Showing 3201 to 3225 of 42,285 assets
Previous
Page 129 of 1692
Next